In this video, the group discusses approaching frontline follicular lymphoma patients, including determining patients who are high risk using symptoms and disease extent.

In this video, the group discusses managing POD24 follicular lymphoma patients, emphasizing clinical trials and preference for T-cell engaging therapies over chemotherapy and transplant.

In this video, the panel discusses promising future combinations in follicular lymphoma, highlighting novel agents paired with rituximab, bispecific antibodies, and CELMoDs like golcadomide in frontline and relapsed settings, while stressing the need for longer follow-up and optimal sequencing.

In this SOHO Insider roundtable discussion, Charalambos (Babis) Andreadis, MD, MS, professor of clinical medicine at University of California, San Francisco, moderates a discussion on